RE: Nut for Peanuts:-)30 Oct 2025 19:03
Thank you SocB,
Difficult to judge which option is best if you do not know all the fine details but I do know believe that big corporations will seek control hence don’t like deals with strings attached, but have no experience in biopharma.
As for the interview, Vlad is a scientist who genuinely exposes the usual challenges that his company faces and not the usual smooth-talking but bs-ing c-suiter who will smother thise challenges behind nice words. At least we can take him at face-value.
As for questioning future trial results and the the fact if patients (yes, patients with a ts at the end) are still alive, everybody on here will rate those points at the level they deserve.
PS, had some posts removed yesterday so no names🙃